Second, inhibiting ANGPTL4 in vivo decreased IL1A production and tumor initiation, the two probably being functionally linked as inhibiting IL1A slows down RAS‐dependent tumor initiation in a pancreatic model (Lau et al. 2019). Here, IL1A is linked to neoplasm.